Skip to main content

Table 2 Plasma levels of TAFI and F 1 + 2 in the groups

From: Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

Variables

Groups

P-value

 

Gastric cancer

Control

 

TAFI Level ± SD (ng/ml)

69.4 ± 33.1

73.3 ±27.5

0.41

F 1 + 2 Level (pmol/l)

549.7 ± 325.3

151.9 ± 67.1

<0.001*